| Literature DB >> 33547483 |
Lucas G Axiotakis1, Deborah M Boyett2, Brett E Youngerman2, Guy M McKhann2, Anil K Lalwani3,4.
Abstract
PURPOSE: Acquiring SARS-CoV-2 infection for uninfected patients undergoing surgical procedures following a COVID positive (COVID+) patient is of significant concern, both for patients seeking medical care in hospital settings and for management of surgical services during pandemic times.Entities:
Keywords: COVID-19 pandemic; Nosocomial infection; Patient safety; Perioperative services
Mesh:
Year: 2021 PMID: 33547483 PMCID: PMC7864797 DOI: 10.1007/s00423-021-02085-0
Source DB: PubMed Journal: Langenbecks Arch Surg ISSN: 1435-2443 Impact factor: 2.895
Nature of perioperative COVID exposures
| COVID+ OR exposures* | Testing status of COVID+ OR patient ( | |||
|---|---|---|---|---|
| Presumed positive | Positive test 1–3 days preop | Positive test >3 days preop | Total | |
| Immediately following COVID+ case | 3 | 0 | 2 | 5 |
| Exposure within 24 h of COVID+ case | 7 | 2 | 14 | 23 |
| Exposure 24–48 h after COVID+ case | 10 | 9 | 10 | 29 |
| Total | 20 | 11 | 26 | 57 |
Table 1 includes all individual instances of exposures to specific COVID+ ORs (n = 57). Number of patients exposed (n = 45) is not shown; this difference is accounted for by n = 9 patients who were exposed to COVID+ ORs on >1 occasion within 48 h
*Time elapsed between a COVID+ patient undergoing surgery followed by a COVID− in the same OR was stratified by (row 1) the next case in the COVID+ OR within the same day, (row 2) within 24 h but not directly following a COVID+ cases within the same day, and (row 3) within 24–48 h of a COVID+ case
**Preoperative COVID+ patients were stratified by (column 1) remote positive testing >3 days preoperatively; (column 2) positive test within 0 to 3 days preoperatively; (column 3) presumed infection based on 2+ of 7 CDC-defined symptoms without testing or with positive test on postoperative day 1 [4]
Fig. 1COVID− surgical patients exposed to COVID+ ORs within 48 h, March 15–May 15. X-axis = study week (7 days each beginning on March 15). Week 9 consists of only 6 days due to the study period end date (ending on May 15). Left Y-axis (bars) = total number of exposures per week of COVID− patients to ORs in which a COVID+ patient had undergone surgery within 48 h. The key indicates screening status of COVID+ patients (presumed positive based on symptoms, or positive testing preoperatively) accounting for OR exposures. Right Y-axis (lines) = weekly averages of daily case counts (diamonds) and number of ORs in use (squares) during the study period, representing the initial peak of the pandemic at our tertiary hospital center